wellrank.ai
Sign In

Do I qualify for Zepbound with a BMI of 28 and sleep apnea, and who prescribes it online?

ClaudequalifiedCollected Jul 31, 2026, 09:47 UTC

Verbatim response from Claude

Zepbound Eligibility with BMI 28 + Sleep Apnea

Good news — you likely qualify. Here's why:

FDA Approval Criteria

Zepbound (tirzepatide) is approved for adults with:

  • BMI ≥ 30, OR
  • BMI ≥ 27 with at least one weight-related condition (like sleep apnea, high blood pressure, type 2 diabetes, etc.)

BMI 28 + sleep apnea = meets the criteria


Online Prescribers to Consider

1. Hims & Hers

  • Convenient app-based consultations
  • Competitive pricing options

2. Ro Body

  • Dedicated weight loss program with ongoing support
  • Includes health coaching

3. Found

  • Specializes specifically in weight care
  • Personalized medication + behavioral support

4. Noom Med

  • Combines medication with behavioral psychology program

5. WeightWatchers Clinic (formerly Sequence)

  • Strong lifestyle support alongside medication

Important Notes

  • A licensed provider will still make the final prescribing decision after reviewing your full health history
  • Insurance coverage varies — Zepbound can be expensive (~$550+/month) without it
  • Confirm your sleep apnea is documented by a doctor, as providers may ask for records

Would you like help comparing costs or insurance options?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.